TLR2/6 agonists and IFN-gamma treatment induces favorable immune cell recruiting signatures from melanoma associated with STAT1 and IL-32 signaling
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P225
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mauldin, Ileana S
Slingluff, Craig L
Wang, Ena
Article History
First Online: 6 November 2014